|

ATG Combined with Tacrolimus and Mini Methotrexate Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Alabama at Birmingham1

Indications

  • GVHD,Acute1
  • Myeloproliferative Disorders1
  • Acute Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Birmingham, Alabama1 trial

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.